Zeb2 Controls Retinal Physiological and Pathological Angiogenesis by Regulating Astrocyte Proliferation and Differentiation
Cell Proliferation · 2026
DOI: 10.1111/cpr.70236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, 2026. Verfasst von Jing Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Zhongshan Ophthalmic Center, Sun Yat-…. Hauptthemen laut MEDLINE: Astrocytes, Zinc Finger E-box Binding Homeobox 2, Cell Differentiation, Retina. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China, Science and Technology Program of Guangzhou.
Abstract (Originalsprache)
Retinal angiogenesis relies on a precisely timed interaction between astrocytes and endothelial cells (ECs), yet the transcriptional regulatory program underlying this complex neurovascular crosstalk remains poorly characterized. Here, we define Zeb2 as a pivotal transcriptional modulator of retinal astrocyte function that coordinates developmental and pathological vascular growth. It is transiently expressed in retinal astrocyte progenitor cells during development and re‐induced under pathological hypoxia. Conditional ablation of Zeb2 in retinal astrocytes enhanced their proliferation, migration, and maturation by upregulating VEGFA and altering other signalling, leading to excessive superficial vascular growth during development. In oxygen‐induced retinopathy, Zeb2 inactivation exacerbated pathological neovascularization while impairing reparative revascularization, which is associated with a transcriptional signature favouring tuft ECs over tip ECs. Mechanistically, it inhibited the neurotoxic A1 astrocyte identity, resulting in dampened inflammatory response and diminished genetic program promoting revascularization and/or preventing neovascularization including Plxnd1, Nrf2, and FGF2 signalling. These findings establish Zeb2 as an oxygen‐sensitive regulator of astrocyte function that differentially modulates physiological and pathological angiogenesis, highlighting its potential as a therapeutic target in proliferative retinopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Brain Function and Disease, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
ORCID-Profile: Dongchang Xiao
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
- Science and Technology Program of Guangzhou
- Science and Technology Planning Project of Guangdong Province
- Fundamental Research Funds of the State Key Laboratory of Ophthalmology
- Guangzhou Municipal Science and Technology Project
Zitieren
APA
Liu, J., Guo, Y., Xiang, K., Wang, S., Xiao, D., & Xiang, M. (2026). Zeb2 Controls Retinal Physiological and Pathological Angiogenesis by Regulating Astrocyte Proliferation and Differentiation. Cell Proliferation. https://doi.org/10.1111/cpr.70236
Vancouver
Liu J, Guo Y, Xiang K, Wang S, Xiao D, Xiang M. Zeb2 Controls Retinal Physiological and Pathological Angiogenesis by Regulating Astrocyte Proliferation and Differentiation. Cell Proliferation. 2026. doi:10.1111/cpr.70236
BibTeX
@article{Liu2026,
author = {Liu, Jing and Guo, Yanan and Xiang, Kangjian and Wang, Shuyi and Xiao, Dongchang and Xiang, Mengqing},
title = {Zeb2 Controls Retinal Physiological and Pathological Angiogenesis by Regulating Astrocyte Proliferation and Differentiation},
journal = {Cell Proliferation},
year = {2026},
doi = {10.1111/cpr.70236}
}
EUVIMED